Results 91 to 100 of about 5,590,035 (204)

Allogeneic hematopoietic cell transplantation for adults with ALL [PDF]

Bone Marrow Transplantation, 2008
ALL is a heterogeneous disease, and outcomes vary by patient age, immunophenotype and clinical, cytogenetic and molecular features. Modern treatment strategies use a risk-adapted approach. The optimal post-remission therapy for adults with ALL remains unclear.
openaire   +2 more sources

Longitudinal assessment of oral intake adequacy and nutrition-impacted symptoms in patients undergoing allogeneic hematopoietic stem cell transplantation

Frontiers in Nutrition
AimsThis study aims to longitudinally assess the adequacy of oral intake and burden of nutrition-impacted symptoms (NIS) and identify modifiable factors associated with oral intake adequacy in allogeneic hematopoietic stem cell transplantation patients ...
Liyuan Qin, Rui Li, Jiaqi Wu, Yang He
doaj   +1 more source

Construction and validation of a risk prediction model for patients complicated with perianal infection after allogeneic hematopoietic stem cell transplantation

Huli yanjiu
ObjectiveTo explore the risk factors for patients complicated with perianal infection after allogeneic hematopoietic stem cell transplantation,and to construct and verify the risk prediction model.MethodsA total of 259 patients who underwent allogeneic ...
WU Xia, YE Hongmin, MA Haixia, HU Pan, DENG Jianchuan, GAN Xiuni   +5 more
doaj  

Successful bone marrow transplantation in a patient with Diamond-Blackfan anemia with co-existing Duchenne muscular dystrophy: a case report

Journal of Medical Case Reports, 2011
Introduction Diamond-Blackfan anemia and Duchenne muscular dystrophy are two rare congenital anomalies. Both anomalies occurring in the same child is extremely rare.
Kaur Jasmeet, Sharma Sanjeevan, Sharma Ajay, Das Satyaranjan, Nair Velu, Mishra DK   +5 more
doaj   +1 more source

Improved outcomes with allogeneic hematopoietic cell transplantation [PDF]

Best Practice & Research Clinical Haematology, 2012
Over the last 2 decades, there have been a number of changes in clinical practice that individually could affect the outcome of allogeneic hematopoietic cell transplantation (HCT), but until recently the collective impact of these changes was unknown. Accordingly, several groups asked the question of whether the outcome of allogeneic HCT has improved ...
openaire   +2 more sources

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

Haematologica, 2011
Background Allogeneic hematopoietic cell transplantation is a potentially curative treatment for patients with acute lymphoblastic leukemia. However, the majority of older adults with acute lymphoblastic leukemia are not candidates for myeloablative ...
Ron Ram, Rainer Storb, Brenda M. Sandmaier, David G. Maloney, Ann Woolfrey, Mary E. D. Flowers, Michael B. Maris, Ginna G. Laport, Thomas R. Chauncey, Thoralf Lange, Amelia A. Langston, Barry Storer, George E. Georges   +12 more
doaj   +1 more source

Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a Novel TYMP Mutation: The Need for Early Diagnosis. [PDF]

, 2012
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a devastating autosomal recessive disorder due to mutations in TYMP, which cause loss of function of thymidine phosphorylase (TP), nucleoside accumulation in plasma and tissues and ...
Padovani Alessandro, SCARPELLI, Mauro, Anna Russignan, Padovani, A, PADOVANI, Alessandro, Bereczki, C, Paola Tonin, Bax Bridget E., Buono, R, Filosto Massimiliano, ZAPPINI, Francesca, Filosto M., Russignan, A, Bridget E. Bax, Alessandro Padovani, Zappini, F, Filosto, M, Bereczki Csaba, Bax, BE, Tonin, P, Massimiliano Filosto, Bax B. E., Padovani A., Zombor, M, Tonin Paola, Buono, Romina, Bereczki C., Zombor Melinda, Zombor M., Mauro Scarpelli, Romina Buono, Zappini Francesca, Scarpelli Mauro, Csaba Bereczki, Russignan Anna, Francesca Zappini, RUSSIGNAN, Anna, Buono Romina, TONIN, PAOLA, Melinda Zombor, Scarpelli, M   +40 more
core   +1 more source

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Haematologica, 2017
Allogeneic blood or marrow hematopoietic cell transplantation continues to be the most potent anti-leukemic treatment for adult patients with standard, high-risk, or chemo-refractory acute myeloid leukemia.
Catherine J Lee, Bipin N Savani, Mohamad Mohty, Myriam Labopin, Annalisa Ruggeri, Christoph Schmid, Frédéric Baron, Jordi Esteve, Norbert C Gorin, Sebastian Giebel, Fabio Ciceri, Arnon Nagler   +11 more
doaj   +1 more source

Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma.

Blood, 2010
Abstract Abstract 4569 Background: Allogeneic hematopoietic cell transplantation (allo HCT) is a potentially curative therapy for multiple myeloma (MM), but has high treatment-mortality (TRM). In addition, disease relapse occurs in a significant number of patients. We sought to evaluate
Bashir, Q., Wei, W., Chiattone, A., Rondon, G., Parmar, S., Shah, N., Booc, E.H., Dinh, Y., Qureshi, S., Shah, J., Orlowski, R.Z., Webber, D., Champlin, R.E., Giralt, S., Qazilbash, M.H.   +14 more
openaire   +1 more source

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Haematologica, 2018
Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation is a frequently fatal complication with no standard therapy. Although significant changes in supportive and intensive care measures for patients undergoing hematopoietic stem cell ...
Fatma Keklik, Ezzideen Barjes Alrawi, Qing Cao, Nelli Bejanyan, Armin Rashidi, Aleksandr Lazaryan, Patrick Arndt, Erhan H. Dincer, Veronika Bachanova, Erica D. Warlick, Margaret L. MacMillan, Mukta Arora, Jeffrey Miller, Claudio G Brunstein, Daniel J. Weisdorf, Celalettin Ustun   +15 more
doaj   +1 more source